Assignee profile:

OPKO RENAL, LLC

City:

Miami, Florida

Country:

United States

Published Applications:

17

Last publication date:

2021-08-05

Patent Grants:

16

Last grant date:

2024-02-27

Top Inventors for applications by OPKO RENAL, LLC

These are the the leading inventors for applications assigned to OPKO RENAL, LLC:

Recent patent applications by OPKO RENAL, LLC

OPKO RENAL, LLC based in Miami, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-08-05 ✅ Patent 11,911,398 granted on 2024-02-27
US20210236517A1
Human necessities

Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D

#2 | 2019-02-28 ✅ Patent 11,007,204 granted on 2021-05-18
US20190060329A1
Human necessities

Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3

#3 | 2018-10-18 ✅ Patent 10,668,089 granted on 2020-06-02
US20180296576A1
Human necessities

Method of treating and preventing secondary hyperparathyroidism

#4 | 2018-02-01 ✅ Patent 11,154,509 granted on 2021-10-26
US20180028453A1
Human necessities

Methods for controlled release oral dosage of a vitamin D compound

#5 | 2018-01-25 ✅ Patent 10,213,442 granted on 2019-02-26
US20180021356A1
Human necessities

Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D

#6 | 2018-01-25 ✅ Patent 11,801,253 granted on 2023-10-31
US20180021355A1
Human necessities

Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease

#7 | 2017-05-04 ✅ Patent 9,925,147 granted on 2018-03-27
US20170119677A1
Human necessities

Method for treating secondary hyperparathyroidism in CKD

#8 | 2017-03-09 ✅ Patent 10,302,660 granted on 2019-05-28
US20170067917A1
Physics

Methods useful for vitamin D deficiency and related disorders

#9 | 2016-12-01 ✅ Patent 9,498,486 granted on 2016-11-22
US20160346299A1
Human necessities

Method for controlled release oral dosage of a vitamin D compound

#10 | 2016-11-17 ✅ Patent 9,913,852 granted on 2018-03-13
US20160331765A1
Human necessities

Method of treating and preventing secondary hyperparathyroidism

#11 | 2015-08-06 ✅ Patent 9,408,858 granted on 2016-08-09
US20150216881A1
Human necessities

Method for treating secondary hyperparathyroidism in CKD

#12 | 2015-05-21 ✅ Patent 9,500,661 granted on 2016-11-22
US20150141385A1
Physics

Methods useful for vitamin D deficiency and related disorders

#13 | 2015-03-19 ✅ Patent 9,943,530 granted on 2018-04-17
US20150079165A1
Human necessities

Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3

#14 | 2014-09-18
US20140274977A1
Human necessities

METHOD OF SAFELY AND EFFECTIVELY TREATING AND PREVENTING SECONDARY HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE

#15 | 2013-07-11 ✅ Patent 9,402,855 granted on 2016-08-02
US20130178451A1
Human necessities

Method of treating and preventing secondary hyperparathyroidism

#16 | 2013-05-23 ✅ Patent 8,778,373 granted on 2014-07-15
US20130131022A1
Human necessities

Methods for controlled release oral dosage of a vitamin D compound

#17 | 2011-03-03 ✅ Patent 8,962,239 granted on 2015-02-24
US20110052567A1
Physics

Methods useful for vitamin D deficiency and related disorders

Also check out OPKO RENAL, LLC's (Miami, United States) applicant profile with 15 patent applications submitted.

AssigneeID:

168501 ⎘